ArticleBlood advances2020
Felber M, Steward CG, Kentouche K, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998-2010.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.